Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "Biocon is a sell. All of a sudden the midcaps stocks are now giving very worrying charts. It is a one way straight line decline, a small trading range is breaking on the downside and it is not stopping. It is a good stock otherwise but it should be a short sell."
At 10:04 hrs Biocon was quoting at Rs 410.75, up Rs 5.90, or 1.46 percent. It has touched an intraday high of Rs 411.85 and an intraday low of Rs 406.60.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
